GlassScriptPhysician profile
Anthony M Hicks
NPI 1225022494
$3,379.88
in general payments reported to CMS, 2019-2025
15 companies · $663 in 2025
The $663 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $189 · 2021: $574 · 2022: $650 · 2023: $487 · 2024: $502 · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,652.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $859.94 | 2019-2025 | Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $733.34 | 2019-2025 | Trelegy Ellipta, Bexsero |
| Lilly USA, LLC | $477.32 | 2020-2025 | Jardiance, Mounjaro, Zepbound |
| Abbott Laboratories | $443.26 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Bayer Healthcare Pharmaceuticals INC. | $218.05 | 2022-2025 | |
| C2n Diagnostics, LLC | $170.35 | 2025 | Precivityad2 |
| Daiichi Sankyo INC. | $112.89 | 2022-2023 | Injectafer |
| Dynavax Technologies Corporation | $93.74 | 2024-2025 | Heplisav-B |
| Dexcom, INC. | $83.01 | 2025 | Dexcom G7 Gss (161) |
| Merck Sharp & Dohme LLC | $52.72 | 2019-2021 | |
| Pfizer INC. | $45.59 | 2019-2025 | |
| Exact Sciences Corporation | $33.22 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Shield Therapeutics INC | $27.23 | 2023 | Accrufer |
| Kowa Pharmaceuticals America, INC. | $15.02 | 2025 | Zoryve |
| Takeda Pharmaceuticals U.S.A., INC. | $14.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Hicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.